POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
Did Not Advance

West Virginia Bill Prohibits Health Insurers from Restricting Patient Access to Clinician-Administered Medications

Original title: Protecting patient access to clinician-administered medications.

Last action · February 12, 2026: To House Health and Human ResourcesSponsor: Matthew Rohrbach

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

West Virginia House Bill 5482 prohibits health insurance issuers and s from restricting coverage, denying payment, or forcing patients to use specific pharmacies for clinician-administered prescription drugs. The measure bars insurers from penalizing providers who obtain drugs outside the insurer's preferred network and subjects violators to penalties under the state's consumer protection laws.

Why it matters

Patients gain the legal right to receive clinician-administered medications from their preferred provider or pharmacy without facing increased fees, steering incentives, or forced delivery of specialty medications to their homes for transport.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

health insurance issuers

Health insurance issuers are prohibited from restricting coverage networks, denying payments, charging extra fees, or steering patients regarding clinician-administered drugs.

Directly affected

pharmacy benefit managers

Pharmacy benefit managers are barred from refusing payments or engaging in prohibited practices regarding clinician-administered medications.

Directly affected

participating providers

Participating providers are guaranteed authorization, approval, and payment for providing covered clinician-administered drugs regardless of where the drugs are sourced.

Directly affected

covered individuals

Covered individuals retain the right to choose their provider or pharmacy for clinician-administered medications without facing increased cost-sharing or mandatory home delivery.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Can health insurers still require patients to use home infusion pharmacies or external infusion sites?
Health benefit issuers may offer the use of a home infusion pharmacy or an external infusion site, but they are explicitly prohibited from requiring them.
What happens if a health insurance contract contains provisions that violate this new article?
Any provision of a contract that is contrary to the provisions of this article is null, void, and unenforceable in West Virginia.
Can insurers deny coverage for a clinician-administered drug based on medical necessity?
Yes, insurers may refuse to authorize or approve coverage based upon failure to satisfy medical necessity criteria, but the location where the drug is received may not be included in those criteria.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

4 actions
  1. Feb 12, 2026HouseCommittee
    To House Health and Human Resources
  2. Feb 12, 2026HouseIntroduced
    Introduced in House
  3. Feb 12, 2026HouseCommittee
    To Health and Human Resources
  4. Feb 12, 2026HouseIntroduced
    Filed for introduction

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Matthew Rohrbach, Drug Supply Chain Security Act, Unfair Trade Practices and Consumer Protection Law
PersonMatthew Rohrbach“Delegate who introduced House Bill 5482”Map →
otherDrug Supply Chain Security Act“Federal law setting supply chain security controls and chain of distribution”Map →
otherUnfair Trade Practices and Consumer Protection Law“State law providing actions, remedies, and penalties for prohibited practices”Map →

Sources

Open source document

www.wvlegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 75)
  • Controversy60
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record